ENTO

Entero Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website -
Employees(FY) -
ISIN US33749P4081

Performance

-17.86%

1W

-30.77%

1M

-68.3%

3M

-66.22%

6M

-50.71%

YTD

-94.09%

1Y

Profile

-

Advanced Technical Analysis

Technical Analysis of ENTO 2024-05-31

Overview:

In analyzing the technical indicators for ENTO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been consistently decreasing, indicating a dow...

Recent News & Updates

2024-05-21 19:00
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention(Globenewswire)
2024-05-19 19:00
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference(Globenewswire)
2024-05-15 19:00
First Wave BioPharma Changes Name to Entero Therapeutics(Globenewswire)
2024-05-14 21:52
FWBI Stock Earnings: First Wave BioPharma Beats EPS for Q1 2024(Investorplace)
2024-05-09 19:55
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market(Globenewswire)
2024-05-08 19:00
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month(Globenewswire)
2024-04-28 21:00
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV(Accesswire)
2024-04-23 19:00
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients(Globenewswire)
2024-04-16 19:00
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase(Globenewswire)
2024-04-14 19:00
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference(Globenewswire)
2024-04-04 21:55
Here's Why First Wave BioPharma (FWBI) Is a Great 'Buy the Bottom' Stock Now(Zacks)
2024-03-27 00:00
First Wave BioPharma (FWBI) Upgraded to Buy: What Does It Mean for the Stock?(Zacks)
2024-03-17 19:00
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference(Yahoo Finance)
2024-03-13 20:05
Why Is First Wave BioPharma (FWBI) Stock Up Today?(Investorplace)
2024-03-13 18:00
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline(Globenewswire)
2024-03-04 18:00
First Wave BioPharma to Participate In 'Fireside Chat' at the 36th Annual Roth Conference(Globenewswire)
2024-03-03 19:00
First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering(Globenewswire)
2024-02-12 18:00
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024(Globenewswire)
2024-01-22 18:00
First Wave BioPharma to Present at the DealFlow MicroCap Conference(Globenewswire)
2024-01-16 18:00
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico(Globenewswire)
2024-01-03 17:00
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024(Globenewswire)
2023-12-26 22:55
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced(Globenewswire)
2023-12-26 21:29
Why Is First Wave Biopharma (FWBI) Stock Up 148% Today?(Investorplace)
2023-12-26 17:00
First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program(Globenewswire)
2023-12-19 21:03
FWBI Stock Earnings: First Wave BioPharma Reported Results for Q1 2023(Investorplace)
2023-12-19 21:03
FWBI Stock Earnings: First Wave BioPharma Beats EPS for Q3 2023(Investorplace)
2023-12-17 17:00
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company(Globenewswire)
2023-12-13 20:15
First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders(Globenewswire)
2023-12-05 18:00
First Wave BioPharma to Participate in BIO Partnering @JPM During J.P. Morgan Week 2024(Globenewswire)
2023-12-04 18:00
First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Conference(Globenewswire)

Page 1 of 4

previousnext